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Biotin
The micronutrient biotin (also known as vitamin H or B7) is a 
small 244 Da watersoluble vitamin essential for life [1-3]. Biotin has a 
well-defined biological function in organisms from all three domains 
of life as a cofactor for biotin-dependent enzymes. These enzymes 
often catalyse key reactions in important metabolic pathways such as 
gluconeogenesis, amino acid metabolism and fatty acid synthesis [4-6]. 
For enzymatic activity, biotin must be covalently attached to a conserved 
lysine residue present in the active site of the biotin-dependent enzyme 
[2,7,8]. The importance of biotin transporters for living organisms is 
exemplified from several perspectives.
Mammals cannot synthesise biotin de novo but efficiently 
accumulate biotin from their environment. This is evidenced by 
congenital abnormality in humans where defects in biotin transport 
results in biotin dependency [9]. Severe deficiency of biotin leads to 
various clinical abnormalities such as growth retardation, neurological 
disorders and skin problems in human patients [5,10,11]. Secondly, 
although many bacteria, Archaea and plants are capable of both 
importing and synthesizing biotin, uptake of the vitamin from the 
environment is energetically more favourable [12]. It requires at least 
6 enzymes and 7 ATP equivalents to synthesise one biotin molecule 
[13]. Hence, having an efficient mechanism to scavenge micronutrients 
may provide an advantage to these organisms especially at important 
stages of their life cycles, such as during pathogenesis. The transport of 
biotin into cells is the subject of this review. Here we have reviewed the 
literature on the recently characterised energy coupling factor (ECF) 
proteins– a family of vitamin transporters in bacteria that includes the 
biotin transporter. Studies into the structure and function of the ABC 
transporters greatly enhance our knowledge about the mechanism of 
solute movement in biotin transport. Biotin transporters from other 
organisms will also be briefly discussed, although these proteins have 
not been as well characterised as the bacterial ECF transporters.
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Abstract
Biotin is an important micronutrient widely employed as an enzyme cofactor in all living organisms, therefore, cells 
that cannot synthesize biotin de novo must import it from the external environment. However, most cells have evolved 
a specific transport protein to facilitate biotin entry into cells, even if they have the necessary biosynthetic pathways, 
as it is more energetically efficient to scavenge biotin from the environment. The best-characterized examples of biotin 
transporters now belong to the bacterial energy coupling factor (ECF) family of vitamin transporters that employ similar 
but distinct mechanisms of solute uptake to the well studied ABC transporters. Here we review recent studies that shed 
new light on the structure and function of these important proteins. Studies on biotin transporters from organisms outside 
the bacterial kingdom are also presented, such as the analogous proteins from yeast, mammals and plants. However, 
there is a paucity of new information here compared to the ECF examples. Possible applications for exploiting biotin 
transporters for drug delivery are also examined.
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ABC and ECF Transporters
ABC transporter
The ATP binding cassette (ABC) transporters are a large family of 
membrane proteins that couple metabolic energy produced from ATP 
hydrolysis to the movement of substrates across cellular membranes 
[14]. ABC transporters are classified as importers (those that mediate 
inward translocation of substrates into the cell) or exporters (those 
that facilitate extrusion of solutes from the cell). The former are 
predominantly present in prokaryotes [15-17], whereas the latter are 
found in both prokaryotes and eukaryotes [18]. ABC importers can 
be grouped into 2 further subtypes based on their topology in the 
membrane [19,20]. Type I importers contain 10-14 trans-membrane 
helices as exemplified by the MalFGK2 protein that has been extensively 
studied using biochemical, biophysical and structural approaches [21]. 
Type II importers have up to 20 trans-membrane helices, allowing them 
to transport substrates that are typically larger than those that use Type 
I importers [22]. The Escherichia coli vitamin B12 importer BtuCDF 
and its homologue HI470 from Haemophilus influenzae are examples of type-II 
importers whose X-ray crystal structures have been reported [23-25].
ECF transporter
The energy coupling factor (ECF) transporters represent the 
smallest subclass of ATP-dependent importers that have recently 
been identified in Archaea and Eubacteria [26,27]. These subclasses of 
integral membrane proteins are the primary facilitators for trafficking 
certain vitamins into microorganisms that may or may not possess 
the enzymes necessary for de novo vitamin biosynthesis [26,28]. All 
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ECF transporters share three common subunits: the solute-binding 
subunit (EcfS), soluble nucleotide-binding subunits required for 
ATP hydrolysis (EcfA) and a membrane embedded permease (EcfT) 
that helps assemble the complex (Figure 1). The structures of the 
ECF transporters most closely resemble the Type I ABC transporters 
described above. ECF transporters are grouped into two classes based 
on their energising modules (Figure 1). Class I transporters employ a 
multisubunit ECF module dedicated for a single EcfS subunit [26]. The 
biotin transporter BioMNY from Rhodobacter capsulatus is the most 
well-characterised example of this class [29]. Class II ECF transporters 
utilise an ECF module encoded by ecfA, ecfA", and ecfT genes that is 
shared by multiple EcfS components and, therefore, actively imports a 
broad range of chemically distinct vitamins [26,30]. While Class I ECFs 
are predominant in Proteobacteria and Actinobacteria, Class II are 
prevalent in Firmicutes [26]. Genes encoding the EcfS, EcfT and EcfA 
subunits are co-located in an operon in the majority of Class I ECF 
transporters. In contrast, the genes for the energising module of Class II 
ECF transporters are present in an operon but separated from the genes 
encoding the EcfS subunit [28,29]. Certain micro-organisms employ 
both Class I and Class II ECF transporters for importing different 
substrates [27]. Co-occurrence of the two classes in these Archea and 
bacteria [28,29] is an unexpected finding.
Molecular Organisation
Extensive biochemical, biophysical and structural data from studies 
on the ABC transporters have provided a great deal of insight into the 
structure and function of these proteins (reviewed [31,32]). In contrast 
the ECF transporters, which have been identified relatively recently, 
have not been as well characterised [27,33]. The available data indicate 
that the ABC and ECF transporters share a number of common but 
distinct structural and functional features. Both contain a binding 
protein for capturing substrate, a means for coupling ATP hydrolysis 
to substrate translocation, and a pathway for transferring substrates 
across the lipid bilayer [19]. In the well-characterised (classical or 
canonical) ABC transporters these entities are represented by four 
or more individual subunits encoded by separate genes [31,32]. The 
core components consist of a pair of hydrophobic trans-membrane 
domains (TMDs) that create the trans-membrane tunnel and two 
soluble ATPase subunits that couple the hydrolysis of ATP to the 
transport of solutes [18]. An additional periplasmic component, 
known as the solute or substrate binding protein (SBP), only found 
in ABC importers, determines substrate specificity by recognising an 
appropriate substrate and delivering it to the translocation pore [34]. 
The molecular organisation of ABC importers in comparison to those 
of ECF transporters are depicted in Figure 1. The ECF transporters 
are functionally analogous to ABC importers but with several notable 
differences. Firstly, the ECF transporters do not possess a SBP that 
brings ligand to the translocation pore. Instead, a membrane integrated, 
substrate-specific protein (the EcfS component) is employed to 
capture and translocate solutes into cells [26,35]. Secondly, ECF 
transporters utilise an energising module (ECF complex) that consists 
of a membrane-bound permease in complex with soluble ATPases 
that reside in the cytoplasm. The stoichiometry of the functional ECF 
transporter complex still requires elucidation. It has been proposed 
that the complex assembles with a 1 EcfA:1 EcfAʹ′,:1 EcfT:1 S subunit 
architecture [26,35-37]. This is supported by data from size exclusion 
chromatography multi-angle light scattering (SEC-MALS) of purified 
complexes and seen in the currently published X-ray crystal structures 
of folate and hydroxymethyl pyrimidine transporter complexes 
reconstituted from purified subunits inproteoliposomes [36,38-40]. 
Other architectures in which one or more EcfS components assemble 
with the ECF module have also been proposed [27,41]. Evidence for 
ECF transporters having more than one EcfS or EcfT subunits have 
come from in vivo FRET assays using fluorescently labelled ECF 
transporters [42]. These different models might be influenced by two 
factors. First, ECF transporters naturally have dynamic stoichiometry, 
allowing them to have one or more Ecf components assembled to the 
ECF module. Alternatively, in vitro reconstitution might not faithfully 
replicate the natural assembly of the native protein complex [36]. The 
subunit stoichiometry of ECF transporters may influence transporter 
activity. This was observed in an in vivo study the biotin transporter 
from R. capsulatus, BioMNY. Import studies using radiolabelled biotin 
were performed with E. coli expressing recombinant BioY (ie the EcfS 
subunit specific for biotin) either alone or in combination with ATPase 
BioM and permease BioN [26]. Surprisingly E. coli cells expressing BioY 
alone were able to mediate substrate transport. Without the dedicated 
BioMN energising module, BioY is a low affinity transporter capable of 
transporting 100-400 nM 3H-biotin [26,29]. This is in contrast to the 
high affinity complex containing BioY, BioM and BioN that performs 
efficient biotin translocation in low (<5 nM) 3H-biotin concentrations 
[29]. The biotin transporter from R. capsulatus is the only prokaryotic 
system that has so far been demonstrated to function in low or high 
affinity states [26,29]. Other vitamin transporters such as ThiT 
(thiamin), RibU (riboflavin), and HmP (hydroxymethyl pirimidine) 
require preassembly with the ECF module for activity [27,36,37]. 
Without the ECF energizing module, these EcfS components can bind 
substrates but are unable to transfer them across biological membranes 
[36,37]. Recombinant BioY proteins from proteobacteria that naturally 
lack an ECF module can only facilitate low affinity biotin import into 
E. coli K12 [36,37].
Structural Biology of the Functional Subunits
In this section we review the literature on the known structures of 
the individual subunits of the ECF transporters with a view to describing 
the assembly of the transporter complexes and how this relates to the 
function of the transporters.
Nucleotide-binding domain
The nucleotide-binding domains (NBDs) in the ATPase subunits 
are hallmarks of ABC transporters due to their high amino acid 
Figure 1: Comparison of subunit architectures of an ABC importer and ECF 
transporters.
For Class 1 transporters the energy-coupling factor is designated for a single 
substrate component, whereas this is shared with different EcfS subunits in 
Class II transporters.
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sequence conservation and their occurrence in all ATP-dependent 
transporters [19]. Conserved structural motifs that are important 
for NBD function include the Walker A (also known as P-loop) and 
B motifs, family signature region (also known as H-loop or C switch 
motif), A-, D-, and Q-loops, and a short LSGGG motif [20,43]. Available 
crystal structures of isolated NBD monomers and dimers show that 
these motifs are segregated into an ATPase subdomain and an α-helical 
subdomain connected by two flexible loops [14,42]. All motifs found 
in the NBD subunits of classical ABC transporters are also present 
in each ATPase subunit of the ECF transporters (Figure 2), implying 
a high degree of functional conservation [29]. Indeed, BioM, EcfA or 
EcfAʹ′, of Thermotoga maritima show high (60%) amino acid sequence 
similarity to the NBD subunits of the classical ABC transporters [27]. 
Conserved motifs in the ATPase of ECF transporters are segregated 
into three subdomains: Rec-A like subdomain, helical subdomain and 
C-terminal subdomain [27,39]. The Rec-A like subdomain is an ATP 
binding site containing the Walker A and Walker B motifs [27,39]. The 
helical subdomain consists of a three-helix bundle with the LSGGQ 
signature critical for nucleotide binding. The C-terminal subdomain 
is a ∼40-residue region that encompasses all regions of the helical 
subdomain [27].
Trans-membrane domain (TMD)
The TMDs of ABC transporters are found as either homo- or 
heterodimers [19,44]. In contrast, the trans-membrane component of 
ECF transporters always consists of two distinct proteins, namely the 
EcfT and EcfS. The permease EcfT shows low sequence similarity to 
the trans-membrane subunits of the classical ABC transporters [45]. 
Between species the sequence identity for the EcfT is <20% [39]. This 
low sequence identity is likely to contribute to the specific assembly of 
functional complexes required for certain vitamins. EcfT is thought 
to be responsible for stabilising the interaction between the EcfS 
component and the soluble ATPases [27,39,42]. X-ray crystal structures 
of folate, hydroxymethyl pyrimidine and pantothenate transporters 
show that EcfT consists of eight α-helices [38,39,46]. The N-terminus 
of the protein resides in the cytoplasm whereas its C-terminus is 
present in the periplasmic compartment. In the membrane, EcfT folds 
into a L-shape structure with one arm formed by five trans-membrane 
helices (H1-4 and H8) and the other arm formed by the periplasmic 
segment consisting of α-helices 5-7 [38,39,46]. This conserved L-shape 
conformation may be essential for transport activity, by bridging EcfS 
with the cytosolic ATPases. In addition, the L shape in EcfT is believed 
to facilitate EcfS to rotate around it, thereby allowing opening of the 
binding pocket to catalyse substrate capture and transport [38].
Substrate component
The ABC importers require a SBP to recognise and capture 
appropriate substrates [19]. The high affinity SBP is also responsible 
for delivering substrate to the open gate of the membrane channel 
formed by the TMD subunits [43]. In contrast to ABC importers, 
ECF transporters employ a membrane embedded EcfS subunit to 
recognise, bind and then transport appropriate substrates into the 
intracellular environment of the cell [26,42,47]. In other words, the 
EcfS component possesses both SBP and TMD functions. The EcfS 
subunits are 20-25 kDa hydrophobic proteins that show low (<25%) 
sequence conservation between homologues and orthologues [37,48]. 
Rodionov and co-workers have identified up to 21 coding regions for 
EcfS components in bacterial genomes [28]. Examples of those that 
have been functionally characterised include BioY (biotin), CbiMN 
(cobalt), NikMN (nickel), RibU (riboflavin), FolT (folate), ThiT 
(thiamin) and PanT (pantothenate) (Figure 3) [26,28,29,49]. Crystal 
structures of six EcfS proteins have now been determined (Figure 3). 
The structures commonly consist of 5-6 trans-membrane helices with 
both N- and C-termini residing in the cytoplasmic region [37-39,46-
48,50]. Structural conservation is observed in their N-terminal trans-
membrane helices consisting of short helix 1-3 (ThiT, FolT and HmP) 
[38,39,46,47] or the short helix 1 and a long V-shaped helix 2 (BioY 
and RibU) [37,48]. The C-terminal trans-membrane helices are highly 
variable consisting of the short individual helix 4 and long helix 5-6 
(Thi and HmP), the long individual helix 4-5 (RibU and BioY) or a 
long U turn helix 5 (FolT) [30,36,37,39,46]. A comparison of the crystal 
structures of the unliganded folate transporter from Lactococcus brevis 
and the folate bound transporter from Enterococcus faecalis shows a 
mobile loop, located between helices 1 and 2, closes over the binding 
site following ligand binding. This structural data has revealed a gating 
mechanism in the FolT to control substrate binding and release that 
may also exist in other transporters that have mobile extra-cellular 
loops, such as BioY, RibU ThiT [30,36].
Intersubunit Interactions
In the classical ABC transporters, TMDs are arranged side by side to 
create a transportation pore along the dimer interface [51]. Each TMD 
Figure 2: ATPase domains of Thermotoga maritima riboflavin transporter.
The EcfA: EcfA" heterodimer is shown. Conserved motifs required for assembly 
and ATPase activity are highlighted. CTD represents C-terminal domain. 
Adapted from [27] using PDB 4HLU.
Figure 3: A comparison of crystal structures EcfS- components.
Shown are the structures of the ECF transporters for thimidine (PDB 3RLB), 
riboflavin (PBD 3P5N), hydroxymethyl pyrimidine (PDB 4HZU), folate (PDB 
4HUQ) and biotin (PDB 4VDE). Individual helical structures are coloured 
with yellow (H-1), green (H-2), red (H-3), cyan (H-4), purple (H-5) and light 
grey (H-6). Internal and external loops were highlighted in magenta and blue, 
respectively whereas a short external helix that may function as a putative lid 
is coloured orange.
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subunit has an intracellular coupling helix that can directly interact 
with a docking groove on the surface of an ATPase subunit [19]. The 
Q-loop in the ATPase contributes residues to the binding interface 
[19]. As a consequence, the complex mediates coupling of ATP derived 
energy production via the NBD subunits with substrate transport in 
the TMD proteins [23]. NBD subunits in the dimer make a head-to-tail 
assembly so that the Walker A motif of one NBD subunit is located next 
to the LSGGQ motif on the partnering subunit. In the nucleotide-free 
state the Walker A and LSGGQ motifs are separated, but come together 
in a closed conformation in the nucleotide bound state [44]. Many 
ATPases of bacterial ABC exporters function as homodimers, but most 
of the eukaryotic equivalents are heterodimers consisting of either 
one or two active ATPases [31,32]. Whilst one of the NBD subunits is 
devoid of a consensus sequence crucial for catalysing ATP hydrolysis, 
it is still required for assembly into a functional ATPase dimer [52]. 
The biological significance of this is not understood. In the ECF 
transporters, direct interactions between the ATPase subunits at the 
dimer interface occur through residues in C-terminal helix-3 of EcfA 
and residues in C-terminal helix-2 of EcfA", (Figure 2) [27,39]. X-ray 
crystal structures of folate and hydroxymethyl pyrimidine transporters 
reveal that the EcfS component sits on the L-shaped cleft of the EcfT 
(Figure 4) [27,39]. This is different from the side-by-side conformation 
found in the classical ABC transporters [31,32]. No significant contacts 
are observed between the EcfS and ATPase components. Therefore, 
the primary interaction between the two subunits is stabilized through 
EcfT [19,33]. The EcfT communicates to each ATPase subunit via 
coupling helices formed by sequences containing two conserved short 
Ala-Arg-Gly motifs [49] located at the C-terminal end of cytoplasmic 
helices 6 and 7 (Figure 4) [27,39]. The interaction between the EcfS and 
EcfT components involves helices 2-3 of EcfS and five helices of EcfT 
(Figure 4) [27,39]. Here, conserved hydrophobic residues in helices 2 
and 3 of the N-terminal domain of the EcfS subunit, containing the 
highly conserved AφφφA signature (where φ is mostly a hydrophobic 
residue) [30], form hydrophobic and hydrogen bonding interactions 
with conserved hydrophobic residues in trans-membrane helices 1-4 
and cytoplasmic helix 6 of EcfT [27,39]. Hydrophobic residues in helix 
6 and loops L3 and L5 of EcfS also participate in the interactions with 
EcfT [27], enforcing the predicted role of EcfT as a stabiliser of the 
complex [26,27,39,42,53]. This structural data also provides a molecular 
explanation as to how EcfT of Class II transporters can interact with 
multiple EcfS components.
Mechanism of solute transport
The translocation pore formed by the TMD subunits of ABC 
transporters is not a continuously open channel [19,23]. This is to avoid 
potentially lethal substrate accumulation or loss due to unregulated 
trafficking [51]. Structural data indicate that ABC importers and 
exporters undergo conformational changes from an ATP-bound open 
(outward facing) structure to an ADP-bound closed (inward facing) 
state [31,32,52]. The SBPs use a ligand-induced “clamping” mechanism 
to uniquely capture appropriate solutes and bring them to the “entry 
gate” of the translocation pore [43]. Substrate binding at the interface 
of the globular domains induces rotation at the hinge [19]. A short-
lived association between the SBP and translocation pore creates a 
transporter-bound SBP shuttle that facilitates substrate delivery from 
the high affinity SBP to the translocation pore [25]. The accepted 
substrate can then diffuse deeper into the channel created in the dimer 
interface between the TMDs. Free energy produced during substrate 
release from the SBP may also enhance substrate movement into the 
pore. Structural rearrangements in the TMDs during this process are 
transmitted to the NBDs that then undergo a conformational change 
ready to bind ATP. Tight dimerization of NBDs upon ATP binding 
brings the coupling helices closer leading to a conformational change 
whereby the TMDs move from an inward to outward facing state. This 
facilitates the movement of the substrate further along the translocation 
pore [19,31]. Finally, ATP hydrolysis and subsequent dissociation 
of ADP and inorganic phosphate drive TMDs to adopt the inward 
facing conformation with the release of substrate into the intracellular 
environment. Here, two ATP equivalents are utilised per reaction cycle 
[52]. The mechanism of solute translocation with the ECF transporters 
has not been as well defined as for the ABC transporters. In fact, it 
is not clear from the available structural and biochemical data how 
the translocation pore is created for solute movement. There are two 
prevailing thoughts as to how the assembly of the ECF transporters 
relates to their function. Here it is reasonable to consider that there 
is no single, universally conserved mechanism that is employed by 
all members of the transporter family. In the first model, it has been 
proposed that that the transport pore resides in the protein interface 
between the EcfS and EcfT subunits [36]. Hence, solute movement 
involves both trans-membrane proteins in a mechanism similar to the 
canonical ABC importers. The second model considers that the EcfS 
protein alone provides the transport path, and large conformational 
Figure 4: The ECF transporter complex for hydroxymethyl pyrimidine from 
Lactococcus brevis.
EcfS (red) binds to the L-shaped helical region of EcfT (dark blue). Coupling 
helices α6 and α7 of EcfT (light blue) are required for binding the soluble 
ATPases. The interaction between the EcfA (green) and EcfA" (orange) is 
facilitated by the C-terminal domains of each protein. Figure adapted from [38] 
using PDB 4HZU.
 
Figure 5: Proposed mechanism of solute uptake.
In this model, EcfS undergoes a 90o rearrangement that permits both binding 
of substrate in the extracellular environment then delivery of the cargo into 
the cytoplasm. The energy required for the translocation is provided by ATP 
hydrolysis. Adapted from [38].
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changes in the membrane facilitate movement of solute from the 
extracellular medium into the cytoplasm (Figure 5). The three crystal 
structures of transporters from L. brevis support this model, with the 
EcfS components all aligning parallel to the membrane and the substrate 
binding pockets positioned next to the cytoplasmic region of the EcfT 
subunit [38,39,46]. Biochemical studies using nanodiscs embedded 
with the biotin transporter from R. capsulatus have provided further 
evidence for this “toppling mechanism” where the S subunit is proposed 
to undergo a 180o conformational change upon ligand binding [38]. By 
substituting specific amino acids in the dimer interface (A12, A13 and 
A17 in the A12AφφφA motif of EcfS and V144 and V147 in coupling 
helix 2 loop of EcfT) with cysteine and using a thiol-reactive crosslinker 
spanning only 25 Å in length, the authors observed that the addition of 
ATP did not disrupt the protein: protein interaction during catalysis 
[54]. This mechanism is plausible for class I transporters, but is not 
sufficient to explain the mechanism for the class II ECFs that utilize one 
shared T component. Recent size exclusion chromatography studies on 
the riboflavin transporter complex from Listeria monocytogenes have 
addressed this issue [40]. In the presence of ATP this ECF complex 
dissociates, suggesting that the S subunit is liberated from the EcfT-
EcfAA" complex in a form competent to rebind ligand. Upon binding 
of the riboflavin the transporter complex reforms, and ATP hydrolysis 
is proposed to drive the 180o conformational change required to move 
ligand across the membrane and deliver it to the cytoplasm. More data 
from structural and biochemical studies will further define the various 
mechanisms underlying solute translocation.
Other biotin transporters
After discussing the ECF biotin transport system utilising BioY in 
prokaryotes, in this section we compare the biotin transport proteins 
from other organisms, specifically E. coli, mammals, yeast and 
plants. These organisms all employ uptake systems that are distinct 
from the ECF system previously described, and are summarised in 
Table 1. The different examples of high affinity transporters for the 
same micronutrient reflect the essential and ubiquitous biological 
function of biotin as an enzyme cofactor found throughout biology. 
These differences also represent opportunities to specifically design 
therapeutic compounds that exploit the biotin transporters to permeate 
biological membranes.
E. coli biotin transporter, YigM
E. coli is a biotin-prototrophic, γ-proteobacterium that is capable 
of biotin import and export [55,56]. It is unclear why this bacterium 
has evolved a biotin uptake system that is distinct from the ECF 
transport system that is widely employed by other bacteria and archea. 
Early biochemical studies indicated that biotin uptake occurs via a 
carrier-facilitated, high affinity and energy dependent mechanism [57]. 
Although a number of studies have been performed over the past 30 
years to characterise this uptake system, the protein responsible has 
only recently been identified [58]. The YigM protein is a 299 amino 
acid protein (MW ∼34 kDa) consisting of 10 trans membrane domains. 
This protein is not structurally related to BioY, but instead belongs to 
the carboxylate/amino acid/amine family of secondary transporters 
[58]. There is no structural data for the YigM protein, and it shows 
no sequence homology with either the yeast or mammalian biotin 
transporters. YigM actively mediates substrate acquisition using 
facilitated diffusion with high affinity for biotin (KM of 74 ± 14 nM) 
[58]. The energy source that drives uptake is unclear, but iodoacetate 
(inhibitor of glycolysis) and azide (inhibitor of electron transport) 
both inhibit biotin uptake [57], implying a role for ATP hydrolysis. The 
prominent role of YigM for biotin transport has been demonstrated 
using a mutant strain of E. coli harbouring the mutant protein YigM 
S28R, P243S defective in biotin transport [58]. However, YigM is 
not the only possible route used by this bacterium to facilitate biotin 
acquisition as E. coli defective in biotin biosynthesis and YgiM are still 
able to grow in medium containing high concentrations of biotin [58]. 
This nonspecific transport might be possible through alternative trans-
membrane proteins, such as aquaporins.
Mammalian Sodium -dependent multivitamin transporter 
(SMVT1)
As mammals are unable to synthesize biotin de novo, organisms in 
this class must satisfy their demand for the micronutrient by uptake 
from exogenous sources. Hence, a high affinity transporter is essential to 
provide cells with sufficient co-factor to sustain the activities of the five 
biotin-dependent enzymes. SMVT1 is the primary transport protein 
that mediates biotin import into mammalian cells. This transporter 
utilises a trans-membrane sodium ion gradient and membrane potential 
to drive active translocation of biotin (Vitamin B7), pantothenic acid 
(Vitamin B5) and lipoic acid into the cell [59-61]. SMVT1 has been 
investigated using intact cells from various mammalian tissues SMVT 
[59,62-65], membrane vesicles [66,67], and nonmammalian oocytes 
recombinantly expressing mammalian SMVT [64]. The SMVT1 is 
a 68,600 Da protein of 636 amino acids [64]. No structural data has 
been reported for SMVT1, but modelling studies propose it is contains 
twelve TMD subunits. It is not known if the protein forms higher order 
complexes either with itself or other regulatory proteins. The protein 
contains three extracellular N-glycosylation sites (N138, N489 and 
N498) and two intracellular consensus sequences for protein kinase 
C-dependent phosphorylation at S283 and T286 [64]. Mutation of the 
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1Number of trans-membrane domains.
Table 1: Summary of biotin transport proteins.
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activity, but did not affect the affinity for biotin, implying a key role of 
the sugar moieties in the activity of the transporter [68]. Likewise, post-
translational phosphorylation of SMVT is utilized to regulate SMVT 
activity [69]. This was demonstrated in colorectal adenocarcinoma cells 
where the addition of protein kinase C activators reduced uptake of 
biotin whereas the presence of kinase inhibitors stimulated its uptake 
[60]. Primary structure analysis reveals a high degree of sequence 
conservation between mammalian SMVTs, with amino acid similarity 
ranging from 89% to 92% [64]. SMVT is widely expressed in various 
tissues such as intestine, liver, brain, heart, lung, kidney, cornea and 
placenta [70]. Therefore SMVT has the potential to be exploited as 
vehicle in drug delivery, as will be discussed later.
Mammalian monocarboxylate transporter (MCT)
MCT1 has also been proposed as an alternative mammalian 
biotin transporter in cells of the lymphoid lineage [71], despite these 
cells also expressing a functional SMVT [69]. In mammalian colonic 
luminal membrane vesicles, MCT1 acts as the main protein that 
facilitates translocation of bicarbonate ions from the colonic lumen 
into colonocytes [72]. Similar to the colonic system, MCT1 in human 
peripheral blood mononuclear cells also facilitates the acquisition 
of biotin into the cells using a proton-dependent counter-transport 
mechanism. MCT1 catalyses translocation of biotin across the cellular 
membrane via the replacement of monocarboxylic acids [71]. As a 
consequence, biotin uptake is inhibited by monocarboxylic compounds 
such as lactate, β-hydroxybutyrate, acetate and hexanoate [71]. MCT1 
is the only transporter reported to facilitate biotin uptake in human 
lymphoid cells [71].
Yeast vitamin H transporter-1 (VHT)
The VHT1 is a membrane transporter protein employed by biotin-
auxotrophic yeast Schizosaccharomyces pombe and Saccharomyces 
cerevisiae to import biotin via a proton (H+)-biotin symport 
mechanism [73-75]. Proton dependency of this permease has been 
confirmed using trans-membrane proton gradient uncouplers [74] and 
activators [76]. VHT1 consists of 593 amino acids (586 in S. pombe) 
that assemble into 12 trans-membrane helices [74,75]. This transporter 
contains a long (120 amino acid residues) N-terminal hydrophilic 
domain, with both N- and C-termini in the cytoplasm [74,75]. In S. 
pombe the trans-membrane helices are segregated into 2 sets of 6 helices 
by a cytoplasmic hydrophilic loop consisting of 71 residues between 
helix 6 and 7 [75]. Two extracellular asparagine residues, present in 
the conserved sequence for N-glycosylation in the S. cerevisiae VHT1, 
N146 (between helix 1 and 2) and N406 (between helix 7 and 8) are 
proposed to be glycosylated during secretion [74]. No mutational 
studies have been performed on VHT1 to establish if the glycosylation 
is essential for activity like it is for SMVT. Biochemical studies show 
that VHT1 is capable of both biotin import and export. Import is 
dependent upon temperature, acidity (pH), and intracellular energy 
levels [76]. Following biotin starvation, biotin uptake reaches a plateau 
after 20 minutes of biotin re-addition. After reaching a maximum 
intracellular concentration, biotin efflux occurs in a temperature and 
pH independent manner [77]. The optimum temperature for uptake 
was determined to be 30°C, and optimum pH ranged from 3.8 to 4.0 
for total or free biotin and 2.8 to 7.0 for protein-bound biotin [76]. 
Uptake was also controlled by the biotin concentration in the growth 
medium [77,78]. VHT1 shows high selectivity for biotin and close 
structural analogues. Using radiolabeled biotin, the M was measured to 
be 3.3 μM. Uptake of the labeled-biotin was inhibited by non-labeled 
biotin and analogues such as homobiotin, norbiotin, desthiobiotin, 
oxybiotin, biotin sulfon, and biotinyl-p-nitrophenyl ester (BNP), but 
not by the precursor 7,8-diaminopelargonic acid (DAPA) nor biocytin 
(N-biotinyl-L-lysine) [75,78]. Although VHT1 belongs to the allantoate 
permease family it cannot\ translocate allantoate or other structurally 
related analogues such as ureidosuccinate and pantothenate [74,75]. 
VHT1 shows no sequence homology to the mammalian SMVT1 [74].
Plant Vitamin H Transporter-1
A proton-dependent symporter for biotin has been reported from 
Arabidopsis thaliana [79]. This transporter, encoded by the AtSUC5 
gene, is the same transporter responsible for sucrose import. It shows 
low sequence conservation with both yeast VHT1 and mammalian 
SMVT1. Unlike yeast VHT1 [74] and mammalian SMVT1 that are 
inhibited by low concentrations of biotin, plant VHT1 mediates the 
uptake of the vitamin in a concentration-dependent manner that 
is not saturable at high concentrations (up to 2 mM) of biotin [79]. 
Deletion of the suc5 gene caused severe delays in embryo growth and 
triacylglycerol production in plants that are also deficient in biotin 
biosynthesis [80]. There has been very little work published on the plant 
transporters.
Possible Application of Biotin Transporter for Drug 
Discovery 
The biotin transporter can be employed for drug delivery because 
of its capability to specifically uptake various biotinylated molecules 
with therapeutic potential. Several studies highlight the utility of this 
approach, despite the mechanisms for the transport being poorly 
understood in most cases. Previous research by Walker and Altman 
reported that Gram-negative E. coli, Salmonella enterica serovar 
Typhimurium and Pseudomonas aeruginosa can import 10 – 31 amino 
acid peptides, with an average molecular weight of 3,900 Da, once 
conjugated with biotin [81]. These peptides were much larger than the 
biggest (∼650 Da) non-biotinylated hexapeptide peptide that could be 
imported by E. coli. The distinct translocation mechanisms employed 
by bacteria and mammals provides a therapeutic window to design 
antibiotics that are selectively imported by bacteria. The example here 
also suggests that therapeutic molecules that are larger than typical 
drug-like, small molecules (molecular weight <500 Da) is achievable. 
This is a welcome finding given the significant amount of research 
activity into developing peptide-based antibiotics. Furthermore, novel 
approaches that improve the permeability of difficult to treat Gram-
negative bacteria may rekindle interest in promising compounds that 
were discarded from antibiotic discovery projects due to poor cell 
penetration activity. Bacterial and yeast systems represent potential 
targets for the delivery of new anti-infectives with applications in 
medicine and agriculture. Transporter targeted delivery has become a 
powerful approach to deliver drugs to target tissues. One noteworthy 
example is acyclovir, a first line drug for the treatment of herpes simplex 
virus infection of the eye. Various strategies have been employed 
to improve the cellular permeability of this compound, including 
synthesizing lipid prodrugs. Vadlapudi et al. generated a biotinylated 
analogue of acyclovir to enhance cellular absorption in the cornea 
[82]. Cellular uptake assays showed that the biotinylated-lipid prodrug 
was a significantly improved substrate over the nonbiotinylated drug. 
The synergistic improvement in bioactivity was proposed to be due to 
the binding of the prodrug to SMVT through the biotinyl moiety and 
increased lipid mediated cellular uptake into cells.
SMVT is overexpressed in a number of cancers [83], an 
observation that can be exploited for the delivery of novel anticancer 
drugs. Camptothecins, that target topoisomerase, are effective anti-
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cancer agents but have significant side effects that limit the dose 
that can be safely administered and, therefore, anti-tumour efficacy. 
Multiple analogues are in development to improve the safety and 
efficacy of this drug class [84]. Chemical modifications in the form of 
biotinylation and PEGylation are amongst the approaches that have 
been explored. Improved cytotoxicity of biotinyl- PEG-camptothecin 
against drug sensitive and drug resistant ovarian carcinoma cell lines 
has been reported [85]. The improved efficacy of the treatment was 
due to enhanced SMVT mediated uptake. Similarly, biotinylation 
and PEGylation of the anti- HIV protease inhibitor saquinavir has 
improved the pharmacokinetics of this drug through by improved 
cellular permeability and inhibition of P-glycopeptide mediated efflux 
[86]. Given the enormous potential of biotin-mediated approaches for 
drug delivery, more research is required to better understand substrate 
specificity and mechanism of biotin transporters in various species.
Acknowledgements
This work was supported by the National Health and Medical Research Council 
of Australia (applications APP1011806 and APP1068885), the Centre for Molecular 
Pathology, University of Adelaide, and Adelaide Research and Innovation’s 
Commercial Accelerator Scheme. AA was the recipient of a scholarship from 
Government of Aceh Province, Syiah Kuala University and the Government of 
Republic of Indonesia. We are grateful to the Carthew family for their financial 
support of this work.
References
1. Polyak SW, Bailey LM, Azhar A, Booker GW (2012) Biotin (Vitamin H or B7). In: 
Betancourt AI, Gaitan HF (eds.) Micronutrients: Sources, properties and health 
benefits. Nova Science Publishers, New York, USA.
2. Polyak SW, Chapman-Smith A (2013) Biotin. In: Lennarz WJ, Lane MD (eds.) 
Encyclopedia of Biological Chemistry. Elsevier, Oxford.
3. Zempleni J, Mock DM (1999) Biotin biochemistry and human requirements. J 
Nutr Biochem 10: 128-138.
4. Knowles JR (1989) The mechanism of biotin-dependent enzymes. Ann Rev 
Biochem 58: 195-221.
5. Sweetman L, Nyhan WL (1986) Inheritable biotin-treatable disorders and 
associated phenomena. Annu Rev Nutr 6: 317-343.
6. Jitrapakdee S, St Maurice M, Rayment I, Cleland WW, Wallace JC, et al. (2008) 
Structure, mechanism and regulation of pyruvate carboxylase. Biochem J 413: 
369-387.
7. Tong L (2013) Structure and function of biotin-dependent carboxylases. Cell 
Mol Life Sci 70: 863-891.
8. Pendini NR, Bailey LM, Booker GW, Wilce MC, Wallace JC, et al. (2008) 
Microbialbiotin protein ligases aid in understanding holocarboxylase synthetase 
deficiency. Biochim Biophys Acta 1784: 973-982.
9. Mardach R, Zempleni J, Wolf B, Cannon MJ, Jennings ML, et al. (2002) Biotin 
dependency due to a defect in biotin transport. J Clin Invest 109: 1617-1623.
10. Zempleni J, Mock DM (2000) Marginal biotin deficiency is teratogenic. Prc Soc 
Exp Biol Med 223: 14-21.
11. Bailey LM, Ivanov RA, Jitrapakdee S, Wilson CJ, Wallace JC, et al. (2008) 
Reduced half-life of holocarboxylase synthetase from patients with severe 
multiple carboxylase deficiency. Hum Mutat 29: 47-57.
12. Abdel-Hamid AM, Cronan JE (2007) Coordinate expression of the 
acetylcoenzyme A carboxylase genes, accB and accC, is necessary for normal 
regulation of biotin synthesis in Escherichia coli. J Bacteriol 189: 369-376.
13. Lin S, Cronan JE (2011) Closing in on complete pathways of biotin biosynthesis. 
Mol Biosyst 7: 1811-1821.
14. Johnson E, Nguyen PT, Yeates TO, Rees DC (2012) Inward facing 
conformations of the MetNI methionine ABC transporter: Implications for the 
mechanism of transinhibition. Prot Sci 21: 84-96.
15. 15. Zhong M, Molday RS (2010) Binding of retinoids to ABCA4, the photoreceptor 
ABC transporter associated with Stargardt macular degeneration. Methods Mol 
Biol 652: 163-176.
16. Kamimoto Y, Terasaka K, Hamamoto M, Takanashi K, Fukuda S, et al. (2012) 
Arabidopsis ABCB21 is a facultative auxin importer/exporter regulated by 
cytoplasmic auxin concentration. Plant Cell Physiol. 53: 2090-2100.
17. Quazi F, Lenevich S, Molday RS (2012) ABCA4 is an N-retinylidenephosphati-
dylethanolamine and phosphatidylethanolamine importer. Nat Commun 3: 925.
18. Hosie AH, Poole PS (2001) Bacterial ABC transporters of amino acids. Res 
Microbiol 152: 259-270.
19. Hollenstein K, Frei DC, Locher KP (2007) Structure of an ABC transporter in 
complex with its binding protein. Nature 446: 213-216.
20. Hohl M, Briand C, Grutter MG, Seeger MA (2012) Crystal structure of a 
heterodimeric ABC transporter in its inward-facing conformation. Nat Struct Mol 
Biol 19: 395-402.
21. Joseph B, Jeschke G, Goetz BA, Locher KP, Bordignon E (2011) Transmembrane 
gate movements in the type II ATP-binding cassette (ABC) importer BtuCD-F 
during nucleotide cycle. J Biol Chem 286: 41008-41017.
22. Locher KP, Lee AT, Rees DC (2002) The E. coli BtuCD structure: a framework 
for ABC transporter architecture and mechanism. Science 296: 1091-1098.
23. Locher KP (2009) Review. Structure and mechanism of ATP-binding cassette 
transporters. Philos Trans R Soc Lond B Biol Sci 364: 239-245.
24. Lewinson O, Lee AT, Locher KP, Rees DC (2010) A distinct mechanism for the 
ABC transporter BtuCD-BtuF revealed by the dynamics of complex formation. 
Nat Struct Mol Biol 17: 332-338.
25. Rodionov DA, Hebbeln P, Eudes A, ter Beek J, Rodionova IA, et al. (2009) 
A novel class of modular transporters for vitamins in prokaryotes. J Bacteriol 
191: 42-51.
26. Karpowich NK, Wang DN (2013) Assembly and mechanism of a group II ECF 
transporter. Proc Natl Acad Sci U S A 110: 2534-2539.
27. Rodionov DA, Hebbeln P, Gelfand MS, Eitinger T (2006) Comparative 
and functional genomic analysis of prokaryotic nickel and cobalt uptake 
transporters: evidence for a novel group of ATP-binding cassette transporters. 
J Bacteriol. 188: 317-327.
28. Hebbeln P, Rodionov DA, Alfandega A, Eitinger T (2007) Biotin uptake 
in prokaryotes by solute transporters with an optional ATP-binding 
cassettecontaining module. Proc Natl Acad Sci U S A 104: 2909-2914.
29. Berntsson RP, ter Beek J, Majsnerowska M, Duurkens RH, Puri P, et al. 
(2012) Structural divergence of paralogous S components from ECF-type ABC 
transporters. Proc Natl Acad Sci U S A 109: 13990-13995.
30. Wilkens S (2015) Structure and mechanism of ABC transporters. F1000prime 
reports 7: 14.
31. ter Beek J, Guskov A, Slotboom DJ (2014) Structural diversity of ABC 
transporters. J Gen Physiol 143: 419-435.
32. Zhang P (2013) Structure and mechanism of energy-coupling factor 
transporters. Trends Microbiol 21: 652-659.
33. Davidson AL, Chen J (2004) ATP-binding cassette transporters in bacteria. 
Annu Rev Biochem 73: 241-68.
34. Ter Beek J, Duurkens RH, Erkens GB, Slotboom DJ (2011) Quaternary 
structure and functional unit of energy coupling factor (ECF)-type transporters. 
J Biol Chem 286: 5471-5475.
35. Erkens GB, Berntsson RP, Fulyani F, Majsnerowska M, Vujicic-Zagar A, et al. 
(2011) The structural basis of modularity in ECF-type ABC transporters. Nat 
Struct Mol Biol 18: 755-760.
36. Zhang P, Wang J, Shi Y (2010) Structure and mechanism of the S component 
of a bacterial ECF transporter. Nature 468: 717-720. 
37. Wang T, Fu G, Pan X, Wu J, Gong X, et al. (2013) Structure of a bacterial 
energy-coupling factor transporter. Nature 497: 272- 226.
38. Xu K, Zhang M, Zhao Q, Yu F, Guo H, et al. (2013) Crystal structure of a folate 
energy-coupling factor transporter from Lactobacillus brevis. Nature 497: 268-271.
39. Siche S, Neubauer O, Hebbeln P, Eitinger T (2010) A bipartite S unit of an 
ECFtype cobalt transporter. Res Microbiol 161: 824-829.
40. Finkenwirth F, Neubauer O, Gunzenhauser J, Schoknecht J, Scolari S, et al. 
(2010) Subunit composition of an energy-coupling-factor-type biotin transporter 
analysed in living bacteria. Biochem J 431: 373-380.
Citation: Azhar A, Booker GW, Polyak SW (2015) Mechanisms of Biotin Transport. Biochem Anal Biochem 4: 210. doi:10.4172/2161-1009.1000210
Volume 4 • Issue 4 • 1000210Biochem Anal BiochemISSN: 2161-1009 Biochem, an open access journal 
Page 8 of 8
41. Davidson AL, Dassa E, Orelle C, Chen J (2008) Structure, function, and 
evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 
72: 317-364.
42. Higgins CF, Linton KJ (2004) The ATP switch model for ABC transporters. Nat 
Struct Mol Biol 11: 918-926.
43. Eitinger T, Rodionov DA, Grote M, Schneider E (2011) Canonical and ECF-
type ATP-binding cassette importers in prokaryotes: diversity in modular 
organization and cellular functions. FEMS Microbiol Rev 35: 3-67.
44. Zhang M, Bao Z, Zhao Q, Guo H, Xu K, et al. (2014) Structure of a pantothenate 
transporter and implications for ECF module sharing and energy coupling of 
group II ECF transporters. Proc Natl Acad Sci U S A 111: 18560-18565.
45. Erkens GB, Majsnerowska M, ter Beek J, Slotboom DJ (2012) Energy coupling 
factor-type ABC transporters for vitamin uptake in prokaryotes. Biochemistry 
51: 4390-4396.
46. Berntsson RP, ter Beek J, Majsnerowska M, Duurkens RH, Puri P, et al. 
(2012) Structural divergence of paralogous S components from ECF-type ABC 
transporters. Proc Natl Acad Sci U S A 109: 13990-13995.
47. Neubauer O, Alfandega A, Schoknecht J, Sternberg U, Pohlmann A, et al. 
(2009) Two essential arginine residues in the T components of energy-coupling 
factor transporters. J Bacteriol 191: 6482-6488.
48. Davidson AL, Maloney PC (2007) ABC transporters: how small machines do a 
big job. Trends Microbiol 15: 448-455.
49. Procko E, Ferrin-O'Connell I, Ng SL, Gaudet R (2006) Distinct structural and 
functional properties of the ATPase sites in an asymmetric ABC transporter. 
Mol Cell 24: 51-62.
50. Neubauer O, Reiffler C, Behrendt L, Eitinger T (2011) Interactions among 
the A and T units of an ECF-type biotin transporter analyzed by site-specific 
crosslinking. PLoS One 6: 29087.
51. Finkenwirth F, Sippach M, Landmesser H, Kirsch F, Ogienko A, et al. (2015) 
ATP-dependent Conformational Changes Trigger Substrate Capture and 
Release by an ECF-type Biotin Transporter. J Biol Chem 290: 16929-16942.
52. Piffeteau A, Zamboni M, Gaudry M (1982) Biotin transport by a biotin-deficient 
strain of Escherichia coli. Biochim Biophys Acta 688: 29-36.
53. Piffeteau A, Gaudry M (1985) Biotin uptake: influx, efflux and countertransport 
in Escherichia coli. Biochim Biophys Acta 816: 77-82.
54. Prakash O, Eisenberg MA (1974) Active transport of biotin in Escherichia coli 
K- 12. J Bacteriol 120: 785-791.
55. Finkenwirth F, Kirsch F, Eitinger T (2013) Solitary BioY proteins mediate biotin 
transport into recombinant Escherichia coli. J Bacteriol 195: 4105-4111.
56. Shi F, Bailey C, Malick AW, Audus KL (1993) Biotin uptake and transport across 
bovine brain microvessel endothelial cell monolayers. Pharm Res 10: 282-288.
57. Said HM (1999) Cellular uptake of biotin: Mechanisms and regulation. J Nutr 
129: 490-493.
58. Weiner D, Wolf B (1991) Biotin uptake, utilization, and efflux in normal and 
biotindeficient rat hepatocytes. Biochem Med Metab Biol 46: 344-363.
59. Grafe F, Wohlrab W, Neubert RH, Brandsch M (2003) Transport of biotin in 
human keratinocytes. J Invest Dermatol 120: 428-433.
60. Prasad PD, Wang H, Kekuda R, Fujita T, Fei YJ, et al. (1998) Cloning and 
functional expression of a cDNA encoding a mammalian sodium-dependent 
vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J 
Biol Chem 273: 7501-7506.
61. Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, et al. (1999) Molecular 
and functional characterization of the intestinal Na+-dependent multivitamin 
transporter. Arch Biochem Biophys 366: 95-106.
62. Said HM, Ortiz A, McCloud E, Dyer D, Moyer MP, et al. (1998) Biotin uptake by 
human colonic epithelial NCM460 cells: a carrier-mediated process shared with 
pantothenic acid. Am J Physiol 275: 1365-1371.
63. Baur B, Baumgartner ER (1993) Na(+)-dependent biotin transport into 
brushborder membrane vesicles from human kidney cortex. Pflugers Arch 422: 
499-505.
64. Said HM, Redha R, Nylander W (1987) A carrier-mediated, Na+ 
gradientdependenttransport for biotin in human intestinal brush-border 
membrane vesicles. Am J Physiol 253: 631-636.
65. Gralla M, Camporeale G, Zempleni J (2008) Holocarboxylase synthetase 
regulates expression of biotin transporters by chromatin remodeling events at 
the SMVT locus. J Nutr Biochem 19: 400-408.
66. Daberkow RL, White BR, Cederberg RA, Griffin JB, Zempleni J (2003) 
Monocarboxylate transporter 1 mediates biotin uptake in human peripheral 
blood mononuclear cells. J Nutr 133: 2703-2706.
67. Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP (1998) 
Identification and characterization of a monocarboxylate transporter (MCT1) in 
pig and human colon: its potential to transport L-lactate as well as butyrate. J 
Physiol 513 (Pt 3): 719-732.
68. Weider M, Machnik A, Klebl F, Sauer N (2006) Vhr1p, a new transcription factor 
from budding yeast, regulates biotin-dependent expression of VHT1 and BIO5. 
J Biol Chem 281: 13513-13524.
69. Stolz J, Hoja U, Meier S, Sauer N, Schweizer E (1999) Identification of the 
plasma membrane H+-biotin symporter of Saccharomyces cerevisiae by 
rescue of a fatty acid-auxotrophic mutant. J Biol Chem 274: 18741-18746.
70. Stolz J (2003) Isolation and characterization of the plasma membrane biotin 
transporter from Schizosaccharomyces pombe. Yeast 20: 221-231.
71. Rogers TO, Lichstein HC (1969) Regulation of biotin transport in Saccharomyces 
cerevisiae. J Bacteriol 100: 565-572.
72. Becker JM, Lichstein HC (1972) Transport overshoot during biotin uptake by 
Saccharomyces cerevisiae. Biochim Biophys Acta 282: 409-420.
73. Rogers TO, Lichstein HC (1969) Characterization of the biotin transport system 
in Saccharomyces cerevisiae. J Bacteriol 100: 557-564.
74. Ludwig A, Stolz J, Sauer N (2000) Plant sucrose-H+ symporters mediate the 
transport of vitamin H. Plant J 24: 503-509.
75. Pommerrenig B, Popko J, Heilmann M, Schulmeister S, Dietel K, et al. (2013) 
Sucrose transporter 5 supplies Arabidopsis embryos with biotin and affects 
triacylglycerol accumulation. Plant J 73: 392-404.
76. Walker JR, Altman E (2005) Biotinylation facilitates the uptake of large peptides 
by Escherichia coli and other gram-negative bacteria. Appl Environ Microbiol 
71: 1850-1855.
77. Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, et al. (2002) Enhancing the 
anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) 
conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. 
Cancer Chemother Pharmacol 50: 143-150.
78. Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, et al. (2006) Functional 
characterization of sodium-dependent multivitamin transporter in MDCKMDR1 
cells and its utilization as a target for drug delivery. Mol Pharm 3: 329-339.
79. Ludwig A, Stolz J, Sauer N (2000) Plant sucrose-H+ symporters mediate the 
transport of vitamin H. Plant J 24: 503-509.
80. Pommerrenig B, Popko J, Heilmann M, Schulmeister S, Dietel K, et al. (2013) 
Sucrose transporter 5 supplies Arabidopsis embryos with biotin and affects 
triacylglycerol accumulation. Plant J 73: 392-404.
81. Walker JR, Altman E (2005) Biotinylation facilitates the uptake of large peptides 
by Escherichia coli and other gram-negative bacteria. Appl Environ Microbiol 
71: 1850-1855.
82. Vadlapudi AD, Vadlapatla RK, Earla R, Sirimulla S, Bailey JB, et al. (2013) 
Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic 
keratitis 28 (HK): transporter recognition, tissue stability and antiviral activity. 
Pharm Res 30: 2063-2076.
83. Bildstein L, Dubernet C, Couvreur P (2011) Prodrug-based intracellular delivery 
of anticancer agents. Adv Drug Del Revs 63: 3-23.
84. Pommier Y (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat 
Rev Cancer 6: 789-802.
85. Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, et al. (2002) Enhancing the 
anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) 
conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. 
Cancer Chemother Pharmacol 50: 143-150.
86. Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, et al. (2006) Functional 
characterization of sodium-dependent multivitamin transporter in MDCKMDR1 
cells and its utilization as a target for drug delivery. Mol Pharm 3: 329-339.
